Navamedic ASA enters exclusive long term distribution agreement with Novozymes for PrecisionBiotics Zenflore® in the Nordics. Through this agreement Navamedic strengthens its position within consumer healthcare and clinically proven probiotics for specific disease areas. The special 1714-Serenitas® live culture in Zenflore® was discovered and developed in partnership with scientists and clinicians from one of the world's leading centres of research on the microbiome and the gut-brain axis, the APC Microbiome Institute at University College Cork, Ireland.

Clinical studies have demonstrated that Bifidobacterium longum 1714 improves the ability to handle stressful situations, supports mental performance and combat mental fatigue. Zenflore® also contains selected Vitamin Bs which contributes to the reduction of fatigue and to sustain normal psychological ability.